Allermont Chewable Tablet 4mg (Montelukast Sodium)
Montelukast Sodium 4.16mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.
MFDS item code 201405468 · Approved 2014.11.24
This product's status changed to Expired on 2024.11.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Relief of allergic rhinitis symptoms; prevention and continuous treatment of asthma
This medication is used to prevent asthma attacks and provide ongoing treatment. It also helps relieve symptoms of seasonal and perennial allergic rhinitis, making it effective for both asthma and allergic rhinitis patients.
Take this medicine once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the time of administration should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet, 1 sachet, or 1 film once daily in the evening. 10 mg tablet Adults and adolescents 15 years of age and older: Administer 10 mg of montelukast orally once daily. 10 mg orally disintegrating film Adults and adolescents 15 years of age and older: Place 10 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water.
Children 6~14 years of age: Chew 5 mg of montelukast once daily. Children 2~5 years of age: Chew 4 mg of montelukast once daily. Children 6~14 years of age: Place 5 mg of montelukast on the tongue once daily and, after it disintegrates, take without water. Children 2~5 years of age: Place 4 mg of montelukast on the tongue once daily and, after it disintegrates, take without water. Children 6~14 years of age: Place 5 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. Children 2~5 years of age: Place 4 mg of montelukast on the tongue once daily, allow it to dissolve, and take without water. Children 6~14 years of age: Administer 5mg of montelukast orally once daily. Asthma Children 2~5 years of age: Administer 4 mg of montelukast orally once daily. Infants 12 months~under 2 years of age: Administer 4 mg of this medicine orally once daily in the evening. Efficacy and safety for asthma have not been established in infants under 12 months of age. Allergic rhinitis Children 2~5 years of age: Administer 4 mg of montelukast orally once daily. Efficacy and safety for seasonal allergic rhinitis have not been established in infants under 2 years of age. Infants 6 months~under 2 years of age: Administer 4mg of this medicine orally once daily. Efficacy and safety for perennial allergic rhinitis have not been established in infants under 6 months of age.
This medication is used for the treatment of asthma and allergic rhinitis and should not be administered to patients who are allergic to it or its components. This medication is not intended for use during acute asthma attacks, so appropriate emergency medication should always be available during such episodes. While you may continue taking this medication if asthma symptoms worsen, do not abruptly stop inhaled corticosteroids or switch to this medicine. In cases of exercise-induced bronchospasm, do not use this medication alone; inhaled beta agonists should be used in conjunction. Patients who have hypersensitivity to aspirin or nonsteroidal anti-inflammatory drugs should avoid these medications while taking this drug. There may be rare, serious side effects such as systemic eosinophilia and vasculitis while taking this drug, so patients should seek medical attention immediately if symptoms such as eosinophilia, skin rash, or pulmonary symptoms worsen. During treatment with this medication, various side effects such as headache, fever, cough, abdominal pain, diarrhea, and rash may occur, and if symptoms persist or worsen, consult healthcare personnel. Use this medication during pregnancy only when necessary, and breastfeeding mothers should be cautious, as this drug may be excreted in breast milk. This medication should not be administered to infants under 6 months of age, as safety and efficacy have not been established. Elderly patients may use this medication, but caution is necessary due to potential differences in age-related responses. In case of overdose, there is no specific antidote, but general symptomatic treatment and clinical monitoring are required. Store this medication out of reach of children, and avoid transferring it to other containers, as it may affect quality. Be sure to take this medication regularly as directed by your doctor, and if symptoms worsen or if you need a short-acting inhaler more frequently, consult your physician. Additionally, if any neuropsychiatric symptoms (e.g., anxiety, agitation, depression, etc.) appear during treatment, notify healthcare personnel immediately. Patients with phenylketonuria should inform healthcare personnel about the phenylalanine content of this medication.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that shields it from light, at room temperature between 1°C and 30°C. Proper storage will help maintain the effectiveness of the medication.
Pink, biconvex, round chewable tablet
28 tablets (7 tablets/PTP × 4)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Montelukast Sodium 4.16mg
Tablet · Prescription medication
Kujoo Pharmaceutical Co., Ltd.

Montelukast Sodium 5.2mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Korea Organon Co., Ltd.
Montelukast Sodium 4.16mg
Prescription medication
Korea Organon Co., Ltd.

Montelukast Sodium 10.4mg
Tablet · Prescription medication
JW Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Montelukast Sodium 4.16mg
Chewable Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.